- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Indian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
3
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
3 companies
Biocon
Market Cap: ₹486.1b
Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.
BIOCON
₹366.10
7D
4.1%
1Y
12.4%
Indoco Remedies
Market Cap: ₹26.5b
Manufactures and markets formulations and active pharmaceutical ingredients in India and internationally.
INDOCO
₹287.80
7D
-2.4%
1Y
-11.0%
Strides Pharma Science
Market Cap: ₹75.1b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.
STAR
₹810.50
7D
1.9%
1Y
-47.8%